Trinity Biotech | TRIB - Selling And Administration Expenses

Stock Price
0.78
Daily Change
-0.04 -4.76%
Monthly
2.15%
Yearly
-15.68%
Q1 Forecast
0.79

Trinity Biotech reported $6.19M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Bayer EUR 3.4B 140M Sep/2025
Bio-Rad Laboratories USD 207.7M 14.2M Jun/2025
EDAP TMS EUR 10.38M 1.15M Jun/2025
J&J USD 6.75B 831M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Siemens EUR 4.1B 526M Sep/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Tosoh JPY 38.9B 1.69B Sep/2025
Trinity Biotech USD 6.19M 2.18M Sep/2025
Veracyte USD 51.73M 5.91M Sep/2025